TegoScience Inc. (KOSDAQ:191420)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,530.00
+390.00 (5.46%)
At close: Aug 11, 2026

TegoScience Revenue

TegoScience had revenue of 1.20B KRW in the quarter ending March 31, 2026, a decrease of -8.69%. This brings the company's revenue in the last twelve months to 5.83B, down -14.28% year-over-year. In the year 2025, TegoScience had annual revenue of 5.94B, down -12.11%.

Revenue (ttm)
5.83B
Revenue Growth
-14.28%
P/S Ratio
10.35
Revenue / Employee
n/a
Employees
42
Market Cap
60.29B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.94B-818.34M-12.11%
Dec 31, 20246.76B-1.01B-13.04%
Dec 31, 20237.77B94.02M1.22%
Dec 31, 20227.68B-621.23M-7.49%
Dec 31, 20218.30B-489.49M-5.57%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
KoBioLabs71.21B
Psomagen60.70B
J2KBIO36.82B
Naturalendo Tech21.69B
PanGen Biotech13.71B
ADBiotech12.51B
QuadMedicine9.78B
NovMetaPharma1.30B
Revenue Rankings